prof. dr. A.S.S. (Alexander) Dömling

Multicomponent reaction chemistry, drug design & early development, structure based drug design, fragment based drug design, computational drug design, proteases, protein protein interactions, receptors, missmutation, orphan disease, inflammation, cancer, metabolic disease

Member of the faculty committee “Healthy Aging”
NWO-CW-FW study group director
Coordinator of MCB seminar series 2013/2014/2015
Cofounder of Carmolex Inc
Cofounder of Carmolex BV
Cofounder of Novel Therapeutics BV
Cofounder of Telesis Pharma BV